메뉴 건너뛰기




Volumn 10, Issue 5, 2004, Pages 655-660

Successful use of ReFacto continuous infusion in two paediatric patients with severe haemophilia A undergoing orthopaedic surgery

Author keywords

B domain deleted recombinant factor VIII; Continuous infusion; Haemophilia A; ReFacto; Surgery

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 8;

EID: 4844222661     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2004.00905.x     Document Type: Article
Times cited : (5)

References (18)
  • 1
    • 84954317027 scopus 로고    scopus 로고
    • Blood-induced joint damage: An overview of musculoskeletal research in haemophilia
    • Rodriguez-Merchan EC, Goddard WJ, Lee CA, eds. Oxford: Blackwell Science
    • Roosendaal G, Van Den Berg HM, Lafeber FPJG, Bijlsma JWJ. Blood-induced joint damage: an overview of musculoskeletal research in haemophilia. In: Rodriguez-Merchan EC, Goddard WJ, Lee CA, eds. Musculoskeletal Aspects of Haemophilia. Oxford: Blackwell Science, 2000: 18-26.
    • (2000) Musculoskeletal Aspects of Haemophilia , pp. 18-26
    • Roosendaal, G.1    Van Den Berg, H.M.2    Lafeber, F.P.J.G.3    Bijlsma, J.W.J.4
  • 2
    • 0035985766 scopus 로고    scopus 로고
    • Treatment strategies in children with hemophilia
    • Petrini P. Treatment strategies in children with hemophilia. Paediatr Drugs 2002; 4: 427-37.
    • (2002) Paediatr. Drugs , vol.4 , pp. 427-437
    • Petrini, P.1
  • 3
    • 0028334619 scopus 로고
    • A practical guide to the evaluation and treatment of hemophilia
    • Furie B, Limentani SA, Rosenfield CG. A practical guide to the evaluation and treatment of hemophilia. Blood 1994; 84: 3-9.
    • (1994) Blood , vol.84 , pp. 3-9
    • Furie, B.1    Limentani, S.A.2    Rosenfield, C.G.3
  • 5
    • 84980270757 scopus 로고
    • Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia
    • Rickard KA. Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia. Haemophilia 1995; 1 (Suppl. 1): 8-13.
    • (1995) Haemophilia , vol.1 , Issue.SUPPL. 1 , pp. 8-13
    • Rickard, K.A.1
  • 6
    • 0036588553 scopus 로고    scopus 로고
    • Orthopaedic surgery of haemophilia in the 21st century: An overview
    • Rodriguez-Merchan EC. Orthopaedic surgery of haemophilia in the 21st century: an overview. Haemophilia 2002; 8: 360-8.
    • (2002) Haemophilia , vol.8 , pp. 360-368
    • Rodriguez-Merchan, E.C.1
  • 7
    • 4844220634 scopus 로고    scopus 로고
    • Management of hemophilia during surgery
    • Forbes CD, Aledort L, Madhok R, eds. London: Chapman & Hall
    • Kobrinsky NL, Stegman DA. Management of hemophilia during surgery. In: Forbes CD, Aledort L, Madhok R, eds. Hemophilia. London: Chapman & Hall, 1997: 237-48.
    • (1997) Hemophilia , pp. 237-248
    • Kobrinsky, N.L.1    Stegman, D.A.2
  • 9
    • 0028061261 scopus 로고
    • Monoclonal purified F VIII for continuous infusion: Stability, microbiological safety and clinical experience
    • Schulman S, Varon D, Keller N, Gitel S, Martinowitz U. Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience. Thromb Haemost 1994; 72: 403-7.
    • (1994) Thromb. Haemost. , vol.72 , pp. 403-407
    • Schulman, S.1    Varon, D.2    Keller, N.3    Gitel, S.4    Martinowitz, U.5
  • 10
    • 0032772907 scopus 로고    scopus 로고
    • Continuous infusion of intermediate-purity factor VIII in haemophilia A patients undergoing elective surgery
    • Rochat C, McFadyen ML, Schwyzer R, Gillham A, Cruickshank A. Continuous infusion of intermediate-purity factor VIII in haemophilia A patients undergoing elective surgery. Haemophilia 1999; 5: 181-6.
    • (1999) Haemophilia , vol.5 , pp. 181-186
    • Rochat, C.1    McFadyen, M.L.2    Schwyzer, R.3    Gillham, A.4    Cruickshank, A.5
  • 11
    • 0033780933 scopus 로고    scopus 로고
    • Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery
    • Batorova A, Martinowitz U. Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery. Br J Haematol 2000; 110: 715-20.
    • (2000) Br. J. Haematol. , vol.110 , pp. 715-720
    • Batorova, A.1    Martinowitz, U.2
  • 12
    • 0036736236 scopus 로고    scopus 로고
    • Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates
    • Dingli D, Gastineau DA, Gilchrist GS, Nichols WL, Wilke JL. Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates. Haemophilia 2002; 8: 629-34.
    • (2002) Haemophilia , vol.8 , pp. 629-634
    • Dingli, D.1    Gastineau, D.A.2    Gilchrist, G.S.3    Nichols, W.L.4    Wilke, J.L.5
  • 13
    • 0036588780 scopus 로고    scopus 로고
    • Continuous infusion of coagulation factors
    • Batorova A, Martinowitz U. Continuous infusion of coagulation factors. Haemophilia 2002; 8: 170-7.
    • (2002) Haemophilia , vol.8 , pp. 170-177
    • Batorova, A.1    Martinowitz, U.2
  • 14
    • 0033669549 scopus 로고    scopus 로고
    • Nursing roles in orthopaedic joint correction in haemophiliac patients
    • Kuhathong K, Chuansumrit A, Keorochana S et al. Nursing roles in orthopaedic joint correction in haemophiliac patients. Haemophilia 2000; 6: 672-6.
    • (2000) Haemophilia , vol.6 , pp. 672-676
    • Kuhathong, K.1    Chuansumrit, A.2    Keorochana, S.3
  • 15
    • 4844223600 scopus 로고    scopus 로고
    • MASAC Recommendations Concerning the Treatment of Patients with Hemophilia and other Bleeding Disorders MASAC Document #151
    • National Hemophilia Foundation. National Hemophilia Foundation, November 9, New York, New York
    • National Hemophilia Foundation. MASAC Recommendations Concerning the Treatment of Patients with Hemophilia and other Bleeding Disorders MASAC Document #151, National Hemophilia Foundation, November 9, 2003, New York, New York.
    • (2003)
  • 16
    • 0037279116 scopus 로고    scopus 로고
    • Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders
    • United Kingdom Haemophilia Centre Doctors' Organisation
    • United Kingdom Haemophilia Centre Doctors' Organisation. Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia 2003; 9: 1-23.
    • (2003) Haemophilia , vol.9 , pp. 1-23
  • 17
    • 0037276262 scopus 로고    scopus 로고
    • The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A
    • Lusher JM, Lee CA, Kessler CM, Bedrosian CL. The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A. Haemophilia 2003; 9: 38-49.
    • (2003) Haemophilia , vol.9 , pp. 38-49
    • Lusher, J.M.1    Lee, C.A.2    Kessler, C.M.3    Bedrosian, C.L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.